CADEX GENOMICS Trademark

Trademark Overview


On Monday, February 11, 2019, a trademark application was filed for CADEX GENOMICS with the United States Patent and Trademark Office. The USPTO has given the CADEX GENOMICS trademark a serial number of 88296676. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by Cadex Genomics, Corp.. The CADEX GENOMICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

Medical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Research and development in the pharmaceutical and biotechnology fields, namely, research and development in the development of testing and information services related to medical diagnostic assays and clinical tests, and medical diagnostic kits used to conduct medical diagnostic assays and clinical tests

Medical testing for diagnostic or treatment purposes, namely, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
cadex genomics

General Information


Serial Number88296676
Word MarkCADEX GENOMICS
Filing DateMonday, February 11, 2019
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6159028
Registration DateTuesday, September 22, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements


Disclaimer with Predetermined Text"GENOMICS"
Goods and ServicesMedical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
Goods and ServicesMedical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Research and development in the pharmaceutical and biotechnology fields, namely, research and development in the development of testing and information services related to medical diagnostic assays and clinical tests, and medical diagnostic kits used to conduct medical diagnostic assays and clinical tests
Goods and ServicesMedical testing for diagnostic or treatment purposes, namely, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2019
Primary Code005
First Use Anywhere DateTuesday, April 16, 2019
First Use In Commerce DateTuesday, April 16, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2019
Primary Code042
First Use Anywhere DateMonday, February 25, 2019
First Use In Commerce DateMonday, February 25, 2019

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 26, 2019
Primary Code044
First Use Anywhere DateMonday, January 13, 2020
First Use In Commerce DateMonday, January 13, 2020

Trademark Owner History


Party NameCadex Genomics, Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Party NameCadex Genomics, Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Party NameCadex Genomics, Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events


Event DateEvent Description
Tuesday, September 22, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, August 18, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, August 15, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 14, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 4, 2020USE AMENDMENT FILED
Thursday, August 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 4, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, February 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 1, 2019ASSIGNED TO LIE
Monday, October 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 29, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 29, 2019NON-FINAL ACTION E-MAILED
Monday, April 29, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 23, 2019ASSIGNED TO EXAMINER
Tuesday, March 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 14, 2019NEW APPLICATION ENTERED IN TRAM